2017 annual financial data
Travere Therapeutics 2017 Operating margin
Direct answer
Operating margin was -34.72%.
Operating income was -53,791,000 USD and net income was -59,731,000 USD.
Operating cash flow was 7,403,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,937,000 USD
- Operating income
- -53,791,000 USD
- Net income
- -59,731,000 USD
- Operating cash flow
- 7,403,000 USD